Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Type I interferons for induction of remission in ulcerative colitis.The Cochrane database of systematic reviews · 2015
   Pooled it
2. Acute Severe Ulcerative Colitis After mRNA Coronavirus Disease 2019 Vaccination: Can mRNA Vaccines Unmask Inflammatory Bowel Diseases?ACG case reports journal · 2022
   Article
3. Gut inflammation induced by drugs: Can pathology help to differentiate from inflammatory bowel disease?United European gastroenterology journal · 2022
   Review
4. Ulcerative colitis triggered by pegylated interferon alpha-2b in a patient with chronic hepatitis B: A case report and literature review.Liver research (Beijing, China) · 2021
   Article
5. Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.Therapeutic advances in neurological disorders · 2021
   Review
6. Secondary causes of inflammatory bowel diseases.World journal of gastroenterology · 2020
   Review
7. Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells.Cancers · 2020
   Article
8. Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice.Scientific reports · 2019
   Article
9. Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa.Cellular and molecular gastroenterology and hepatology · 2017
   Article
10. Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report.BMC gastroenterology · 2016
    Article
11. Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2013
    Article
12. Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?Frontiers in immunology · 2013
    Article
13. Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.World journal of gastroenterology · 2012
    Review
14. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis.Gut · 2011
    Article
15. Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.PloS one · 2011
    Article
16. Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels.Clinical and experimental immunology · 2010
    Article
17. Peptidoglycan recognition proteins protect mice from experimental colitis by promoting normal gut flora and preventing induction of interferon-gamma.Cell host & microbe · 2010
    Article
18. Hepatitis C virus and inflammatory bowel disease.Digestive diseases and sciences · 2009
    Review
19. Large intestine histopathology of pegylated-interferon-alpha plus ribavirin treated chronic hepatitis C patients.Gastroenterology research and practice · 2008
    Article
20. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.World journal of gastroenterology · 2007
    Article

Corrections and comments

• Comment on
  A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.2003

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as